Literature DB >> 17965279

Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats.

Heather Macarthur1, Thomas C Westfall, Gerald H Wilken.   

Abstract

Current evidence suggests that hyperactivity of the sympathetic nervous system and endothelial dysfunction are important factors in the development and maintenance of hypertension. Under normal conditions the endothelial mediator nitric oxide (NO) negatively modulates the activity of the norepinephrine portion of sympathetic neurotransmission, thereby placing a "brake" on the vasoconstrictor ability of this transmitter. This property of NO is diminished in the isolated, perfused mesenteric arterial bed taken from the spontaneously hypertensive rat (SHR), resulting in greater nerve-stimulated norepinephrine and lower neuropeptide Y (NPY) overflow from this mesenteric preparation compared with that of the normotensive Wistar-Kyoto rat (WKY). We hypothesized that increased oxidative stress in the SHR contributes to the dysfunction in the NO modulation of sympathetic neurotransmission. Here we demonstrate that the antioxidant N-acetylcysteine reduced nerve-stimulated norepinephrine and increased NPY overflow in the mesenteric arterial bed taken from the SHR. Furthermore, this property of N-acetylcysteine was prevented by inhibiting nitric oxide synthase with N(omega)-nitro-l-arginine methyl ester, demonstrating that the effect of N-acetylcysteine was due to the preservation of NO from oxidation. Despite a reduction in norepinephrine overflow, the nerve-stimulated perfusion pressure response in the SHR mesenteric bed was not altered by the inclusion of N-acetylcysteine. Studies including the Y(1) antagonist BIBO 3304 with N-acetylcysteine demonstrated that this preservation of the perfusion pressure response was due to elevated NPY overflow. These results demonstrate that the reduction in the bioavailability of NO as a result of elevated oxidative stress contributes to the increase in norepinephrine overflow from the SHR mesenteric sympathetic neuroeffector junction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965279     DOI: 10.1152/ajpheart.01040.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.

Authors:  Chen Huei Leo; Hooi Hooi Ng; Sarah A Marshall; Maria Jelinic; Thusitha Rupasinghe; Chengxue Qin; Ute Roessner; Rebecca H Ritchie; Marianne Tare; Laura J Parry
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

Review 2.  Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.

Authors:  H Macarthur; G H Wilken; T C Westfall; L L Kolo
Journal:  Acta Physiol (Oxf)       Date:  2011-03-01       Impact factor: 6.311

Review 3.  Endothelium-dependent contractions: when a good guy turns bad!

Authors:  Paul M Vanhoutte; Eva H C Tang
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

Review 4.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

Review 5.  Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors.

Authors:  Michel Félétou; Tony J Verbeuren; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2009-01-19       Impact factor: 8.739

6.  Sympathetic regulation of vascular function in health and disease.

Authors:  Rosa M Bruno; Lorenzo Ghiadoni; Gino Seravalle; Raffaella Dell'oro; Stefano Taddei; Guido Grassi
Journal:  Front Physiol       Date:  2012-07-24       Impact factor: 4.566

7.  Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.

Authors:  Shinji Takai; Denan Jin; Shizuka Aritomi; Kazumi Niinuma; Mizuo Miyazaki
Journal:  Hypertens Res       Date:  2012-11-29       Impact factor: 3.872

8.  Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system.

Authors:  Jeanie Park
Journal:  Cardiol Res Pract       Date:  2012-08-07       Impact factor: 1.866

9.  Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis.

Authors:  Dorothea D Jenkins; Donald B Wiest; Denise M Mulvihill; Anthony M Hlavacek; Sarah J Majstoravich; Truman R Brown; Joseph J Taylor; Jason R Buckley; Robert P Turner; Laura Grace Rollins; Jessica P Bentzley; Kathryn E Hope; Andrew B Barbour; Danielle W Lowe; Renee H Martin; Eugene Y Chang
Journal:  J Pediatr       Date:  2015-11-03       Impact factor: 4.406

10.  Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.

Authors:  Mahesh Kumar Seth; M Ejaz Hussain; Santosh Pasha; Mohammad Fahim
Journal:  Drug Des Devel Ther       Date:  2016-04-20       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.